Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Marcus & Millichap Inc is a real estate services business based in the US. Marcus-and-Millichap shares (MMI) are listed on the NYSE and all prices are listed in US Dollars. Marcus-and-Millichap employs 764 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$44.52|
|52-week range||$29.69 - $45.41|
|50-day moving average||$40.90|
|200-day moving average||$38.56|
|Wall St. target price||$37.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$1.91|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-08)||2.91%|
|1 month (2021-09-17)||12.99%|
|3 months (2021-07-16)||22.95%|
|6 months (2021-04-16)||18.37%|
|1 year (2020-10-16)||42.92%|
|2 years (2019-10-17)||24.53%|
|3 years (2018-10-17)||38.18%|
|5 years (2016-10-17)||86.90%|
Valuing Marcus-and-Millichap stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Marcus-and-Millichap's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Marcus-and-Millichap's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 23x. In other words, Marcus-and-Millichap shares trade at around 23x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Marcus-and-Millichap's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.82. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Marcus-and-Millichap's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Marcus-and-Millichap's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $112.8 million.
The EBITDA is a measure of a Marcus-and-Millichap's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$877.7 million|
|Operating margin TTM||11.52%|
|Gross profit TTM||$269 million|
|Return on assets TTM||8.49%|
|Return on equity TTM||13.73%|
|Market capitalisation||$1.8 billion|
TTM: trailing 12 months
There are currently 391,919 Marcus-and-Millichap shares held short by investors – that's known as Marcus-and-Millichap's "short interest". This figure is 19.1% down from 484,724 last month.
There are a few different ways that this level of interest in shorting Marcus-and-Millichap shares can be evaluated.
Marcus-and-Millichap's "short interest ratio" (SIR) is the quantity of Marcus-and-Millichap shares currently shorted divided by the average quantity of Marcus-and-Millichap shares traded daily (recently around 82509.263157895). Marcus-and-Millichap's SIR currently stands at 4.75. In other words for every 100,000 Marcus-and-Millichap shares traded daily on the market, roughly 4750 shares are currently held short.
However Marcus-and-Millichap's short interest can also be evaluated against the total number of Marcus-and-Millichap shares, or, against the total number of tradable Marcus-and-Millichap shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Marcus-and-Millichap's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Marcus-and-Millichap shares in existence, roughly 10 shares are currently held short) or 0.0157% of the tradable shares (for every 100,000 tradable Marcus-and-Millichap shares, roughly 16 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Marcus-and-Millichap.
Find out more about how you can short Marcus-and-Millichap stock.
We're not expecting Marcus-and-Millichap to pay a dividend over the next 12 months.
Over the last 12 months, Marcus-and-Millichap's shares have ranged in value from as little as $29.6901 up to $45.41. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Marcus-and-Millichap's is 0.818. This would suggest that Marcus-and-Millichap's shares are less volatile than average (for this exchange).
Marcus & Millichap, Inc. , an investment brokerage company, provides real estate investment brokerage and financing services to sellers and buyers of commercial real estate in the United States and Canada. The company offers commercial real estate investment sales, financing, research, and advisory services for multifamily, retail, office, industrial, single-tenant net lease, seniors housing, self-storage, hospitality, medical office, and manufactured housing. It also operates as a financial intermediary that provides commercial real estate capital markets solutions, including senior debt, mezzanine debt, joint venture, and preferred equity, as well as loan sales and consultative/due diligence services to commercial real estate owners, developers, investors, and capital providers. In addition, the company provides various ancillary services, including research, advisory, and consulting services to developers, lenders, owners, real estate investment trusts, high net worth individuals, pension fund advisors, and other institutions. It has a strategic alliance with M&T Realty Capital Corporation. Marcus & Millichap, Inc.
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.